Mylan to Acquire Meda

Go back to Mylan to Acquire Meda

Mylan (MYL) Shares Look to Stabilize After Pounding on 'Desparate' Meda Deal

February 11, 2016 11:09 AM EST

Mylan (NASDAQ: MYL) is attempting to stabilize as investors express disappointment with the Meda deal, sending the stock in free-fall. Analysts called the deal,... More

RBC Capital Views Mylan's (MYL) Meda Purchase as Desperate - PT to $58

February 11, 2016 8:05 AM EST

RBC Capital reiterated a Sector Perform rating on Mylan (NASDAQ: MYL), and cut the price target to $58.00 (from $60.00), following the company's announcement that they will acquire Meda for $9.9 billion. Separately, MYL missed 4Q. Neither will help the stock and this deal feels desperate in RBC's... More

Mylan (MYL) Misses Q4 EPS by 5c

February 10, 2016 4:13 PM EST

Mylan (NASDAQ: MYL) reported Q4 EPS of $1.22, $0.05 worse than the analyst estimate of $1.27. Revenue for the quarter came in at $2.49 billion versus the consensus estimate of $2.7 billion.

GUIDANCE:

Mylan sees FY2016 EPS of $4.85-$5.15, versus the consensus of $4.90.

For earnings history and earnings-related data on Mylan (MYL) click here.

... More